Clinical Trial Update: Plasmonic Nanophotothermal Therapy of Atherosclerosis [NA]

View source ↗

Summary

A completed clinical trial evaluating plasmonic nanophotothermal therapy for atherosclerosis with related cardiovascular conditions; results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Heart Failure
• Multivessel Coronary Artery Disease
• Stable Angina

Drugs mentioned

• Plasmonic nanophotothermal therapy

Snippet

Sponsor: Ural State Medical University | Conditions: Stable Angina, Heart Failure | NA | Status: COMPLETED | Results posted: 2012-08-30